Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats

Neurochemical Research

Volumn 37, Issue 8, 2012, Pages 1660-1669

  Da Cunha, Aline A ^a   Ferreira, Andréa G K ^a   Loureiro, Samanta O ^a   Da Cunha, Maira J ^a   Schmitz, Felipe ^a   Netto, Carlos Alexandre ^a   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Acetylcholinesterase activity; Cytokines; Hyperhomocysteinemia; NF B p65 subunit; Nitrite levels; Prostaglandin E 2

Indexed keywords

ACETYLCHOLINESTERASE; HOMOCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRATE; PROSTAGLANDIN E2; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; HIPPOCAMPUS; HYPERHOMOCYSTEINEMIA; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; RAT;

ACETYLCHOLINESTERASE; ANIMALS; BIOLOGICAL MARKERS; CHEMOKINE CCL2; DINOPROSTONE; HIPPOCAMPUS; HOMOCYSTINURIA; HYPERHOMOCYSTEINEMIA; INTERLEUKIN-1BETA; INTERLEUKIN-6; NITRITES; RATS; RATS, WISTAR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS; RATTUS NORVEGICUS;

EID: 84864353396     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0769-2     Document Type: Article

References (76)

1. Mudd SH, Levy HL, Skovby F (2001) Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1279-1327
2. Mattson MP, Kruman II, Duan W (2002) Folic acid and homocysteine in age-related disease. Ageing Res Rev 1:95-111
3. Sachdev P (2004) Homocysteine and neuropsychiatric disorders. Rev Bras Psiquiatr 26:50-56
4. Regland B (2005) Schizophrenia and single-carbon metabolism. Prog Neuropsychopharmacol Biol Psychiatry 29:1124-1132
5. Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338:1042-1050
6. Diaz-Arrastia R (2000) Homocysteine and neurologic disease. Arch Neurol 57:1422-1427
7. Zou CG, Banerjee R (2005) Homocysteine and redox signaling. Antioxid Redox Signal 7:547-559
8. Tyagi N, Gillespie W, Vacek JC et al (2009) Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 by ERK pathway. J Cell Physiol 220:257-266
9. da Cunha AA, Ferreira AG, Wyse AT (2010) Increased inflammatory markers in brain and blood of rats subjected to acute homocysteine administration. Metab Brain Dis 25:199-206
10. Das UN (2006) Clinical laboratory tools to diagnose inflammation. Adv Clin Chem 41:189-229
11. Wang T, Zhang X, Li JJ (2002) The role of NF-κB in the regulation of cell stress responses. Int Immunopharmacol 2:1509-1520
12. Hawiger J (2001) Innate immunity and inflammation: a transcriptional paradigm. Immunol Res 23:99-109
13. Csiszar A, Wang M, Lakatta EG et al (2008) Inflammation and endothelial dysfunction during aging: role of NF-kappaB. J Appl Physiol 105:1333-1341
14. Dallot E, Méhats C, Oger S et al (2005) A role for PKCzeta in the LPS-induced translocation NF-kappaB p65 subunit in cultured myometrial cells. Biochimie 87:513-521
15. Ghirnikar RS, Lee YL, Eng LF (1998) Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem Res 23:329-340
16. Lucas SM, Rothwell NJ, Gibson RM (2006) The role of inflammation in CNS injury and disease. Br J Pharmacol 147: S232-S240
17. Das UN (2007) Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Med Sci Monit 13:RA214-RA221
18. Andriantsitohaina R, Surprenant A (1992) Acetylcholine released from guinea-pig submucosal neurones dilates arterioles by releasing nitric oxide from endothelium. J Physiol 453:493-502
19. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
20. Weiss N, Keller C, Hoffmann U et al (2002) Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med 7:227-239
21. Gori AM, Corsi AM, Fedi S et al (2005) A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am J Clin Nutr 82:335-341
22. Keating AK, Freehauf C, Jiang H et al (2011) Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria. Mol Genet Metab 103:330-337
23. Sung FL, Slow YL, Wang G et al (2001) Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis. Mol Cell Biochem 216:121-128
24. Poddar R, Sivasubramanian N, DiBello PM et al (2001) Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 103:2717-2723
25. +-ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia. Neurochem Res 27: 1593-1598
26. Zanotto-Filho A, Gelain DP, Schröder R et al (2009) The NFkappaB-mediated control of RS and JNK signaling in vitamin A-treated cells: duration of JNK-AP-1 pathway activation may determine cell death or proliferation. Biochem Pharmacol 77:1291-1301
27. Green LC, Wagner DA, Glogowski J et al (1982) Analysis of nitrate, nitrite and [15 N]nitrate in biological fluids. Anal Biochem 126:131-138
28. Wallace JL, Morris GP, Beck PL et al (1988) Effects of sucralfate on gastric prostaglandin and leukotriene synthesis: relationship to protective actions. Can J Physiol Pharmacol 66:666-670
29. Ellman GL, Courtney KD, Andres V Jr (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95
30. Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275
31. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
32. Li Q, Verma IM (2002) NF-kB regulation in the immune system. Nat Rev Immunol 2:725-734
33. Clarke R, Daly L, Robinson K et al (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149-1155
34. Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354:407-413
35. Cook JW, Taylor LM, Orloff SL et al (2002) Homocysteine and arterial disease. Experimental mechanisms. Vasc Pharmacol 38: 293-300
36. Nappo F, De Rosa N, Marfella R, De Lucia D et al (1999) Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 281: 2113-2118
37. Woo KS, Qiao M, Chook P et al (2002) Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention. J Card Surg 17:432-435
38. Dalal S, Parkin SM, Homer-Vanniasinkam S et al (2003) Effect of homocysteine on cytokine production by human endothelial cells and monocytes. Ann Clin Biochem 40:534-541
39. Su SJ, Huang LW, Pai LS et al (2005) Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression. Nutrition 21:994-1002
40. Giulian D, Chen J, Ingeman JE et al (1989) The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 9:4416-4429
41. Clinton SK, Libby P (1992) Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med 116:1292-1300
42. Wang G, Siow YL, Karmin O (2000) Homocysteine stimulates nuclear factor kB activity and monocyte chemoattractant protein-1 expression in vascular smooth muscle cells: a possible role for protein kinase C. Biochem J 352:817-826
43. Hofmann MA, Lalla E, Lu Y et al (2001) Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107:675-683
44. Wang G, Woo CW, Sung FL et al (2002) Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules. Arterioscler Thromb Vasc Biol 22:1777-1783
45. Postea O, Krotz F, Henger A et al (2006) Stereospecific and redoxsensitive increase in monocyte adhesion to endothelial cells by homocysteine. Arterioscler Thromb Vasc Biol 26:508-513
46. Rongioletti M, Baldassini M, Papa F et al (2005) Homocysteinemia is inversely correlated with platelet count and directly correlated with sE-and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase. Platelets 16:185-190
47. Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615
48. Rekka EA, Chrysselis MC (2002) Nitric oxide in atherosclerosis. Mini Rev Med Chem 2:585-593
49. Nathan C, Xie QW (1994) Nitric oxide synthase: roles, tolls and controls. Cell 78:915-918
50. Cooke JP, Losordo DW (2002) Nitric oxide and angiogenesis. Circulation 105:2133-2135
51. Naseem KM (2005) The role of nitric oxide in cardiovascular diseases. Mol Aspect Med 26:33-65
52. Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315-424
53. Welch GN, Upchurch GR Jr, Farivar RS et al (1998) Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-κ β-dependent transcriptional activation of Nod 2. Proc Assoc Am Physicians 110:22-31
54. Stamler JS, Osborne JA, Jaraki O et al (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308-318
55. Zhang X, Li H, Jin H et al (2000) Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol 279:F671-678
56. Tyagi N, Moshal KS, Ovechkin AV et al (2005) Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia. J Cell Biochem 96:665-671
57. Jiang X, Yang F, Tan H et al (2005) Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol 25:2515-2521
58. Woo CW, Cheung F, Chan VW et al (2003) Homocysteine stimulates inducible nitric oxide synthase expression in macrophages: antagonizing effect of ginkgolides and bilobalide. Mol Cell Biochem 243:37-47
59. Postea O, Krotz F, Henger A et al (2006) Stereospecific and redox-sensitive increase in monocyte adhesion to endothelial cells by homocysteine. Arterioscler Thromb Vasc Biol 26: 508-513
60. Berenbaum F (2000) Proinflammatory cytokines, prostaglandins, and the chodrocyte: mechanisms of intracellular activation. Jt Bone Spine 67:561-564
61. Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871-1875
62. Serhan CN, Levy B (2003) Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics. Proc Natl Acad Sci USA 100:8609-8611
63. Bombardier S, Cattani P, Ciabattoni G et al (1981) The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and non-steroidal anti-inflammatory drugs. Br J Pharmacol 73:893-901
64. Amin AR, Attur M, Patel RN et al (1996) Superinduction of cyclooxygenase-2 activity in human osteoarthritisaffected cartilage: influence of nitric oxide. J Clin Invest 99:1231-1237
65. Kim SF, Huri DA, Snyder SH (2005) Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310:1966-1970
66. Au-Yeung KK, Woo CW, Sung FL et al (2004) Hyperhomocysteinemia activates nuclear factor-kappaβ in endothelial cells via oxidative stress. Circ Res 94:28-36
67. Bai YP, Liu YH, Chen J et al (2007) Rosiglitazone attenuates NFkappaB-dependent ICAM-1 and TNF-alpha production caused by homocysteine via inhibiting ERK1/2/p38MAPK activation. Biochem Biophys Res Commun 360:20-26
68. Zhang L, Jin M, Hu XS et al (2006) Homocysteine stimulates nuclear factor kappaB activity and interleukin-6 expression in rat vascular smooth muscle cells. Cell Biol Int 30:592-597
69. Matté C, Mackedanz V, Stefanello FM et al (2009) Chronic hyperhomocysteinemia alters antioxidant defenses and increases DNA damage in brain and blood of rats: protective effect of folic acid. Neurochem Int 54:7-13
70. Streck EL, Vieira PS, Wannmacher CM et al (2003) In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metab Brain Dis 18:147-154
71. Li N, Karin M (1999) Is NF-kappaB the sensor of oxidative stress? FASEB J 13:1137-1143
72. +-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem Res 27:1685-1689
73. Borovikova LV, Ivanova S, Zhang M et al (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458-462
74. Hofer S, Eisenbach C, Lukic IK et al (2008) Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med 36:404-408
75. Pollak Y, Gilboa A, Ben-Menachem O et al (2005) Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production. Ann Neurol 57:741-745
76. Ofek K, Krabbe KS, Evron T et al (2007) Cholinergic status modulations in human volunteers under acute inflammation. J Mol Med 85:1239-1251